|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 50 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-28 |
4 |
S |
$19.90 |
$238,175 |
I/I |
(11,868) |
223,686 |
|
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2010-04-06 |
4 |
B |
$20.00 |
$268,620 |
I/I |
13,431 |
83,467 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$103,080 |
I/I |
5,102 |
92,236 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$3,212,600 |
I/I |
159,010 |
3,427,082 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$760,813 |
I/I |
37,657 |
1,210,700 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$2,437,148 |
I/I |
(112,218) |
2,068,321 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$2,135,616 |
I/I |
(98,334) |
1,746,038 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$469,825 |
I/I |
(21,633) |
47,428 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$413,293 |
I/I |
(19,030) |
140,977 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$531,786 |
I/I |
(24,486) |
257,293 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$344,252 |
I/I |
(15,851) |
119,247 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$2,692,747 |
I/I |
(123,987) |
2,273,231 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$260,138 |
I/I |
(11,978) |
231,648 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2022-03-08 |
4 |
OE |
$22.05 |
$882,000 |
I/I |
40,000 |
33,059,604 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-23 |
4 |
B |
$22.87 |
$32,029 |
I/I |
1,400 |
135,596 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-23 |
4 |
B |
$22.87 |
$1,160,710 |
I/I |
50,735 |
4,985,725 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-24 |
4 |
B |
$23.43 |
$46,933 |
I/I |
2,002 |
137,598 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-24 |
4 |
B |
$23.43 |
$1,700,598 |
I/I |
72,542 |
5,058,267 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$23,269 |
I/I |
968 |
138,566 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$843,196 |
I/I |
35,078 |
5,093,345 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$2,938 |
I/I |
120 |
1,253,773 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$21,986 |
I/I |
898 |
162,557 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$519,553 |
I/I |
21,221 |
6,087,950 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$7,430,585 |
I/I |
297,340 |
5,601,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$205,095 |
I/I |
8,207 |
152,590 |
2.25 |
- |
|
1397 Records found
|
|
Page 50 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|